Walleye Capital’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.3K Sell
191
-266,996
-100% -$24.4M ﹤0.01% 4404
2026
Q1
$9.91M Buy
267,187
+262,480
+5,576% +$8.4M 0.04% 406
2025
Q4
$95K Buy
4,707
+274
+6% +$6.63K ﹤0.01% 3893
2025
Q3
$133K Buy
+4,433
New +$96K ﹤0.01% 3558
2025
Q1
Sell
-28,718
Closed -$478K 4172
2024
Q4
$478K Buy
28,718
+8,957
+45% +$119K ﹤0.01% 3032
2024
Q3
$254K Buy
19,761
+713
+4% +$10.3K ﹤0.01% 3831
2024
Q2
$213K Sell
19,048
-57,671
-75% -$672K ﹤0.01% 4255
2024
Q1
$951K Buy
+76,719
New +$1.28M ﹤0.01% 2640
2023
Q1
Sell
-41,477
Closed -$1.34M 3878
2022
Q4
$834K Buy
+41,477
New +$887K 0.02% 1109

Other funds holding AEHR

Walleye Capital's AEHR Position: Q2 2026 in Review

Walleye Capital reduced its Aehr Test Systems (AEHR) stake by 100% in Q2 2026, selling an estimated $24.4M and leaving 191 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4404.

Walleye Capital first reported a position in AEHR in Q4 2022 and has held it in 9 quarters since. The position peaked at $9.91M in Q1 2026. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • Walleye Capital held 191 shares of Aehr Test Systems worth $18.3K as of Q2 2026.
  • Walleye Capital sold 266,996 Aehr Test Systems shares in Q2 2026, an estimated $24.4M.
  • Aehr Test Systems made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4404 holding.
  • Walleye Capital first reported a position in Aehr Test Systems in Q4 2022 and has held it in 9 quarters since.
  • Walleye Capital's Aehr Test Systems position peaked at $9.91M in Q1 2026.
  • 262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.